Parkinsonism syndrome due to cephaloridine.
D000328:Adult; D002509:Cephaloridine / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism; D004569:Electroencephalography; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D013378:Substantia Nigra / Q000378:metabolism
D002509:Cephaloridine